CERT1 and early-onset autosomal dominant Alzheimer disease: In neurodegenerative diseases, studies have suggested that GPBP/CERT may be involved in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [9].